Celldex Therapeutics Inc
NASDAQ:CLDX
Income Statement
Earnings Waterfall
Celldex Therapeutics Inc
Revenue
|
6.9m
USD
|
Operating Expenses
|
-148.9m
USD
|
Operating Income
|
-142m
USD
|
Other Expenses
|
613k
USD
|
Net Income
|
-141.4m
USD
|
Income Statement
Celldex Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
4
N/A
|
2
-48%
|
3
+23%
|
3
+5%
|
4
+32%
|
4
+2%
|
5
+43%
|
5
-1%
|
5
+6%
|
6
+15%
|
6
-13%
|
7
+22%
|
7
+1%
|
7
+3%
|
9
+35%
|
11
+18%
|
13
+14%
|
15
+20%
|
14
-7%
|
11
-21%
|
10
-15%
|
7
-28%
|
5
-30%
|
4
-8%
|
4
-20%
|
5
+37%
|
4
-10%
|
5
+3%
|
7
+64%
|
5
-27%
|
9
+60%
|
8
-6%
|
5
-43%
|
4
-11%
|
1
-80%
|
1
+32%
|
2
+121%
|
3
+33%
|
3
+3%
|
4
+34%
|
7
+58%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(86)
|
(98)
|
(108)
|
(115)
|
(126)
|
(126)
|
(131)
|
(133)
|
(135)
|
(141)
|
(139)
|
(138)
|
(140)
|
(139)
|
(138)
|
(129)
|
(121)
|
(99)
|
(208)
|
(71)
|
(56)
|
(60)
|
(53)
|
(57)
|
(57)
|
(55)
|
(50)
|
(53)
|
(53)
|
(73)
|
(63)
|
(66)
|
(72)
|
(82)
|
(83)
|
(94)
|
(103)
|
(128)
|
(125)
|
(139)
|
(149)
|
|
Selling, General & Administrative |
(15)
|
(16)
|
(18)
|
(19)
|
(21)
|
(22)
|
(26)
|
(29)
|
(34)
|
(37)
|
(37)
|
(35)
|
(36)
|
(34)
|
(33)
|
(31)
|
(25)
|
(23)
|
(22)
|
(21)
|
(19)
|
(19)
|
(17)
|
(17)
|
(15)
|
(14)
|
(14)
|
(14)
|
(14)
|
(15)
|
(16)
|
(18)
|
(20)
|
(23)
|
(26)
|
(27)
|
(27)
|
(27)
|
(27)
|
(29)
|
(31)
|
|
Research & Development |
(67)
|
(80)
|
(89)
|
(95)
|
(104)
|
(102)
|
(105)
|
(103)
|
(100)
|
(103)
|
(102)
|
(102)
|
(103)
|
(101)
|
(100)
|
(97)
|
(96)
|
(92)
|
(89)
|
(79)
|
(66)
|
(56)
|
(44)
|
(44)
|
(43)
|
(43)
|
(43)
|
(42)
|
(43)
|
(44)
|
(46)
|
(49)
|
(53)
|
(58)
|
(66)
|
(74)
|
(82)
|
(92)
|
(98)
|
(110)
|
(118)
|
|
Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(4)
|
0
|
1
|
18
|
(96)
|
29
|
30
|
15
|
8
|
3
|
1
|
3
|
7
|
4
|
4
|
(14)
|
(1)
|
1
|
1
|
(1)
|
9
|
7
|
7
|
(9)
|
0
|
0
|
0
|
|
Operating Income |
(81)
N/A
|
(96)
-17%
|
(105)
-10%
|
(112)
-7%
|
(122)
-9%
|
(122)
+0%
|
(126)
-3%
|
(128)
-2%
|
(130)
-1%
|
(134)
-4%
|
(134)
+0%
|
(132)
+2%
|
(133)
-1%
|
(132)
+0%
|
(129)
+3%
|
(118)
+9%
|
(109)
+8%
|
(83)
+23%
|
(194)
-133%
|
(60)
+69%
|
(47)
+22%
|
(53)
-13%
|
(48)
+9%
|
(52)
-8%
|
(53)
-2%
|
(50)
+6%
|
(46)
+9%
|
(48)
-5%
|
(45)
+6%
|
(67)
-48%
|
(55)
+19%
|
(58)
-5%
|
(68)
-17%
|
(78)
-15%
|
(82)
-6%
|
(93)
-13%
|
(100)
-8%
|
(124)
-24%
|
(121)
+3%
|
(135)
-11%
|
(142)
-5%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
1
|
2
|
4
|
4
|
4
|
4
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
3
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
3
|
6
|
8
|
10
|
13
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
(13)
|
(123)
|
0
|
(110)
|
(110)
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
(4)
|
(4)
|
(18)
|
0
|
(15)
|
(18)
|
(4)
|
0
|
(19)
|
(15)
|
(15)
|
0
|
0
|
0
|
(13)
|
|
Pre-Tax Income |
(82)
N/A
|
(94)
-15%
|
(103)
-10%
|
(108)
-5%
|
(118)
-9%
|
(118)
0%
|
(122)
-3%
|
(126)
-3%
|
(127)
-1%
|
(132)
-4%
|
(131)
+0%
|
(129)
+2%
|
(129)
+0%
|
(128)
+0%
|
(125)
+3%
|
(127)
-2%
|
(117)
+7%
|
(202)
-72%
|
(190)
+6%
|
(165)
+13%
|
(152)
+8%
|
(50)
+67%
|
(46)
+9%
|
(50)
-9%
|
(51)
-2%
|
(46)
+9%
|
(46)
+1%
|
(49)
-6%
|
(61)
-26%
|
(65)
-6%
|
(67)
-3%
|
(73)
-10%
|
(71)
+4%
|
(77)
-9%
|
(100)
-29%
|
(106)
-6%
|
(112)
-6%
|
(119)
-6%
|
(113)
+5%
|
(125)
-10%
|
(141)
-13%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
6
|
6
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(82)
|
(94)
|
(103)
|
(108)
|
(118)
|
(118)
|
(122)
|
(126)
|
(127)
|
(132)
|
(131)
|
(129)
|
(129)
|
(128)
|
(125)
|
(122)
|
(112)
|
(196)
|
(184)
|
(165)
|
(151)
|
(50)
|
(46)
|
(50)
|
(51)
|
(46)
|
(46)
|
(48)
|
(60)
|
(64)
|
(66)
|
(72)
|
(71)
|
(77)
|
(100)
|
(106)
|
(112)
|
(119)
|
(113)
|
(125)
|
(141)
|
|
Net Income (Common) |
(82)
N/A
|
(94)
-15%
|
(103)
-10%
|
(108)
-5%
|
(118)
-9%
|
(118)
0%
|
(122)
-3%
|
(126)
-3%
|
(127)
-1%
|
(132)
-4%
|
(131)
+0%
|
(129)
+2%
|
(129)
+0%
|
(128)
+0%
|
(125)
+3%
|
(122)
+3%
|
(93)
+23%
|
(177)
-90%
|
(165)
+7%
|
(146)
+12%
|
(151)
-4%
|
(50)
+67%
|
(46)
+9%
|
(50)
-9%
|
(51)
-2%
|
(46)
+9%
|
(46)
+2%
|
(48)
-6%
|
(60)
-24%
|
(64)
-7%
|
(66)
-4%
|
(72)
-9%
|
(71)
+2%
|
(77)
-9%
|
(100)
-29%
|
(106)
-6%
|
(112)
-6%
|
(119)
-6%
|
(113)
+5%
|
(125)
-10%
|
(141)
-13%
|
|
EPS (Diluted) |
-14.72
N/A
|
-15.81
-7%
|
-17.14
-8%
|
-18.17
-6%
|
-19.81
-9%
|
-19.21
+3%
|
-18.63
+3%
|
-19.22
-3%
|
-19.66
-2%
|
-20.01
-2%
|
-19.92
+0%
|
-19.21
+4%
|
-18.99
+1%
|
-15.66
+18%
|
-14.93
+5%
|
-14.06
+6%
|
-10.85
+23%
|
-18.87
-74%
|
-16.75
+11%
|
-13.34
+20%
|
-14.48
-9%
|
-4.08
+72%
|
-3.27
+20%
|
-3.26
+0%
|
-3.51
-8%
|
-2.65
+25%
|
-2.06
+22%
|
-1.23
+40%
|
-2.02
-64%
|
-1.6
+21%
|
-1.67
-4%
|
-1.58
+5%
|
-1.64
-4%
|
-1.64
N/A
|
-2.14
-30%
|
-2.26
-6%
|
-2.4
-6%
|
-2.52
-5%
|
-2.4
+5%
|
-2.64
-10%
|
-2.92
-11%
|